Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 95 of 1714:
85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, gamma subunit 8 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TROGLITAZONE Calcium Channel Type L, Dihydropyridine 62% NoneNone NoneNone View
opioid receptor, sigma 1 ECONAZOLE Sigma1 62% 21.109uM 8.872uM View
androgen receptor MICONAZOLE Testosterone 62% 7.089uM 4.726uM View
cannabinoid receptor 1 (brain) MICONAZOLE Cannabinoid CB1 62% 21.05uM 16.614uM View
Cytochrom P450-2C19 monooxygenase BISACODYL CYP450-2C19 Inhibition 62% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type IX, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage gated, type VIII, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type VII, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type IV, beta VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type IV, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type III, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type II, beta VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type II, alpha 2 VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type I, beta VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
sodium channel, voltage-gated, type I, alpha VINBLASTINE Sodium Channel, Site 2 62% 25.191uM 22.585uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit ALPHA-ERGOCRYPTINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ALPHA-ERGOCRYPTINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ALPHA-ERGOCRYPTINE Calcium Channel Type L, Phenylalkylamine 62% NoneNone NoneNone View
acetylcholinesterase (YT blood group) VECURONIUM BROMIDE Acetylcholinesterase 65% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase VECURONIUM BROMIDE Acetylcholinesterase 65% NoneNone NoneNone View
acetylcholinesterase VECURONIUM BROMIDE Acetylcholinesterase 65% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B LY-294002 Serotonin 5-HT2B 65% 36.707uM 23.359uM View
adenosine A2a receptor 4-OCTYLPHENOL Adenosine A2A 65% 22.432uM 12.593uM View
thromboxane A synthase 1 4-OCTYLPHENOL Thromboxane Synthetase 65% 66.049uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) 4-OCTYLPHENOL Thromboxane Synthetase 65% 66.049uM NoneNone View
phosphodiesterase 5A, cGMP-specific BACITRACIN Phosphodiesterase PDE5 65% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific BACITRACIN Phosphodiesterase PDE5 65% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PHENOTHIAZINE Dopamine Transporter 65% 18.636uM 14.807uM View
dopamine receptor D1A CELECOXIB Dopamine D1 65% 27.994uM 13.997uM View
calcium channel, voltage-dependent, beta 3 subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 KETOTIFEN Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a KETOTIFEN Serotonin 5-HT3 64% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b KETOTIFEN Serotonin 5-HT3 64% NoneNone NoneNone View
adrenergic receptor, alpha 2b SELEGILINE Adrenergic alpha2C 64% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) SELEGILINE Adrenergic alpha2C 64% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 SAQUINAVIR CYP450-3A4 Inhibition 64% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 NANDROLONE Glucocorticoid 64% NoneNone NoneNone View
cholinergic receptor, muscarinic 3 OXYMETAZOLINE Muscarinic M3 64% NoneNone NoneNone View
mitogen activated protein kinase 1 CANDESARTAN Protein Serine/Threonine Kinase, ERK2 64% NoneNone NoneNone View
mitogen-activated protein kinase 1 CANDESARTAN Protein Serine/Threonine Kinase, ERK2 64% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase IDEBENONE CYP450-1A2 Inhibition 64% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific SB-203580 Phosphodiesterase PDE5 64% 11.476uM NoneNone View
phosphodiesterase 5A, cGMP-specific SB-203580 Phosphodiesterase PDE5 64% 11.476uM NoneNone View
opioid receptor, kappa 1 BENZETHONIUM CHLORIDE Opiate kappa 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 NISOLDIPINE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NELFINAVIR Calcium Channel Type L, Benzothiazepine 64% 14.59uM 12.969uM View
5-hydroxytryptamine (serotonin) receptor 1A TERBINAFINE Serotonin 5-HT1A 64% NoneNone NoneNone View
Protein-tyrosine kinase, Fyn TERCONAZOLE Protein Tyrosine Kinase, Fyn 64% 10.896uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi AMLODIPINE GABAA, Agonist Site 8% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ROSIGLITAZONE Calcium Channel Type L, Phenylalkylamine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit METERGOLINE Calcium Channel Type L, Dihydropyridine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit METERGOLINE Calcium Channel Type L, Dihydropyridine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit METERGOLINE Calcium Channel Type L, Dihydropyridine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit METERGOLINE Calcium Channel Type L, Dihydropyridine 64% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit METERGOLINE Calcium Channel Type L, Dihydropyridine 64% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel associated protein 1 TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel associated protein 2 TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide TIBOLONE Sodium Channel, Site 2 63% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C TROPISETRON Serotonin 5-HT2C 62% NoneNone NoneNone View
dopamine receptor D3 SAQUINAVIR Dopamine D3 62% 15.366uM 5.219uM View
adrenergic receptor, beta 3 FLUNARIZINE Adrenergic beta3 62% NoneNone NoneNone View
histamine receptor H 2 OLANZAPINE Histamine H2 62% NoneNone NoneNone View
opioid receptor, sigma 1 EBASTINE Sigma1 62% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase PROMETHAZINE CYP450-2D6 Inhibition 62% NoneNone NoneNone View
histamine receptor H 1 DAPIPRAZOLE Histamine H1, Central 62% NoneNone NoneNone View
opioid receptor, delta 1 SPIRONOLACTONE Opiate delta 62% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase BAY 11-7085 CYP450-1A2 Inhibition 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel associated protein 1 EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel associated protein 2 EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha EMETINE Sodium Channel, Site 2 62% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 HALOPROGIN Cyclooxygenase COX-1 62% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) HALOPROGIN Cyclooxygenase COX-1 62% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific TRIOXSALEN Phosphodiesterase PDE4 62% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific TRIOXSALEN Phosphodiesterase PDE4 62% NoneNone NoneNone View
phosphodiesterase 4D TRIOXSALEN Phosphodiesterase PDE4 62% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific TRIOXSALEN Phosphodiesterase PDE4 62% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
sodium channel, voltage-gated, type XI, alpha CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
sodium channel, voltage-gated, type I, beta CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CELECOXIB Sodium Channel, Site 2 62% 16.854uM 15.111uM View